Reimbursement News Reimbursement news and insurance coverage updates. Concert Genetics New Test ID Tool Works to Improve Reimbursement Process Premium The company previously launched its Concert Coding Engine to help standardize how genetic tests are coded and how labs can bill for them. Genomic Testing Cooperative's Hematologic Neoplasms, Solid Tumor Tests Receive NY State Approval, Medicare Coverage The next-generation sequencing-based tests can be performed on small samples, including needle aspiration samples, and use artificial intelligence software. Veracyte Bladder Cancer Test Receives Medicare Coverage The patient must be a candidate for multiple potential treatments with varying levels of intensity or multiple therapies. Roche, Canadian Organizations Launch Real-World Evidence Framework in British Columbia The aim within the initiative is to generate and assess real-world evidence, and use the data to support reimbursement for precision oncology therapies. Postponed CMS Proposal Would Remove Unspecified Cancer Dx Codes, Impacting Test Access Premium The proposed change would delete payable cancer codes if they contain the word "unspecified" even if the word is included in a code that doesn't impact coverage. May 21, 2021 Palmetto Releases Draft LCD for Prostate Cancer Risk Stratification Tests May 10, 2021 Medicare Expands Coverage for Hologic's Biotheranostics Breast Cancer Test Apr 22, 2021 Medicare Administrative Contractor Palmetto Finalizes Coverage of Molecular Testing for Organ Transplant Rejection Mar 16, 2021 New AMP Survey Reports Insufficient Reimbursement for Analysis, Interpretation of MDx Test Results Jan 26, 2021 Genomind Receives Medicare Coverage for Pharmacogenetics Test Jan 20, 2021 CMS Finalizes Blood-Based Colon Cancer Screening NCD with Non-Coverage for Epi ProColon Dec 8, 2020 Illumina, Harvard Pilgrim Health Care Ink Risk-Sharing Deal for Whole-Genome Sequencing Dec 3, 2020 Aetna Updates Noninvasive Prenatal Testing Coverage Policy to Include All Pregnancies Dec 3, 2020 Local Coverage Determinations Roundup: Castle Bio Dec 2, 2020 Diaceutics, Alva10 Gathering Evidence Base for Improving PD-L1 Test Reimbursement Premium Dec 1, 2020 UnitedHealthcare to Cover NIPT for Average-Risk Pregnancies Nov 19, 2020 CGS Administrators Aligns Medicare Coverage for CareDx AlloSure Tests Nov 13, 2020 Clinical Genomics Nabs Medicare Coverage for Colorectal Cancer Test as Novitas Revises LCD Nov 6, 2020 Medicare Administrative Contractor CGS Aligns Coverage for Melanoma Risk Stratification Tests Oct 29, 2020 Humana Broadens Coverage of NIPT for Average Risk Pregnancies Oct 28, 2020 Strata Oncology Receives Medicare Coverage for NGS Test Oct 22, 2020 Local Coverage Determinations Roundup: CareDx, Castle Bio, Decipher Biosciences Oct 15, 2020 Germany Grants National Reimbursement for Three Additional Breast Cancer Biomarker Tests Oct 13, 2020 Palmetto Cease-and-Desist Letter to Reimbursement Expert Raises Questions About Pricing Transparency Premium Oct 12, 2020 Pacific Edge Diagnostics Receives Medicare Coverage for Bladder Cancer Test Load More Breaking News Ancient DNA Analysis Highlights Three Ancestral Populations in Japan FDA Warns of Potential False Positives With Abbott SARS-CoV-2 Molecular Tests New Products Posted to GenomeWeb: Oxford Nanopore, Beckman Coulter, Thermo Fisher Scientific, More People in the News: New Appointments at Sema4, NHGRI, Dante Labs, Ancestry, More Thermo Fisher Scientific Expects 12 Percent Revenue Growth in 2022 In Brief This Week: Myriad Genetics, Danaher, Co-Diagnostics, and More The Scan For Those Thick Tiger Stripes Tigers in India with thick stripes harbor a genetic change, as Gizmodo reports. High GABA Tomatoes The Japan News reports that genome-edited tomatoes with higher GABA levels are now for sale in Japan. Approach for Inclusivity and Diversity A National Human Genome Research Institute team calls for the field to "adopt diversity as an ethos." Science Papers on Tumors Immune System Evasion; Drivers of Genomic Instability, Inflammation In Science this week: study of how tumors evade the adaptive immune system, and more.